{"url_path":"/sec/celz/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1187953/0001477932-26-002893-index.html","accession_number":"0001477932-26-002893","cik":"0001187953","ticker":"CELZ","issuer_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1187953/0001477932-26-002893-index.html","primary_entity_key":"0001187953","primary_entity_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC."},"word_count":283,"has_tables":true,"body_markdown":"**Item 6. Exhibits**\n\n \n\n**Exhibits**\n\n \n\n \n\n[3.1.1](http://www.sec.gov/Archives/edgar/data/1187953/000147793221001495/celz_ex31.htm)\n\n \n\n[Articles of Incorporation of Creative Medical Technology Holdings, Inc., a Nevada corporation (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 17, 2021).](http://www.sec.gov/Archives/edgar/data/1187953/000147793221001495/celz_ex31.htm)\n\n[3.1.2](http://www.sec.gov/Archives/edgar/data/1187953/000147793224008314/celz_ex31.htm)\n\n \n\n[Certificate of Amendment to Articles of Incorporation Pursuant to NRS 78.385 and 78.390, as filed with the Secretary of State of the State of Nevada on December 19, 2024 (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 26, 2024).](http://www.sec.gov/Archives/edgar/data/1187953/000147793224008314/celz_ex31.htm)\n\n[3.2](http://www.sec.gov/Archives/edgar/data/1187953/000107878208001636/jolleyform10ex32.htm)\n\n \n\n[Bylaws of Creative Medical Technology Holdings, Inc., a Nevada corporation (incorporated by reference to Exhibit 3.2 to the Company’s Form 10 filed with the Securities and Exchange Commission on November 18, 2008).](http://www.sec.gov/Archives/edgar/data/1187953/000107878208001636/jolleyform10ex32.htm)\n\n[31.1](celz_ex311.htm)\n\n \n\n[Rule 13a-14(a)/15d-14a(a) Certification of Principal Executive Officer*](celz_ex311.htm)\n\n[31.2](celz_ex312.htm)\n\n \n\n[Rule 13a-14(a)/15d-14a(a) Certification of Principal Financial Officer*](celz_ex312.htm)\n\n[32.1](celz_ex321.htm)\n\n \n\n[Section 1350 Certification of Principal Executive Officer *](celz_ex321.htm)\n\n[32.2](celz_ex322.htm)\n\n \n\n[Section 1350 Certification of Principal Financial Officer *](celz_ex322.htm)\n\n101.INS\n\n \n\nInline XBRL Instance Document\n\n101.SCH\n\n \n\nInline XBRL Taxonomy Extension Schema Document\n\n101.CAL\n\n \n\nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF\n\n \n\nInline XBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB\n\n \n\nInline XBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE\n\n \n\nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\n \n\n* \n\nFiled herewith.\n\n \n\n \n\n25\n\n*Table of Contents*\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n**Creative Medical Technology Holdings, Inc.**\n\n \n\n \n\n \n\n \n\n \n\nDate: May 8, 2026\n\nBy\n\n*/s/ Timothy Warbington*\n\n \n\n \n\n \n\nTimothy Warbington, Chief Executive Officer\n\n \n\n \n\n \n\n(Principal Executive Officer) \n\n \n\n \n\n \n\n \n\n \n\nDate: May 8, 2026\n\nBy\n\n*/s/ Donald Dickerson*\n\n \n\n \n\n \n\nDonald Dickerson, Chief Financial Officer\n\n \n\n \n\n \n\n(Principal Financial Officer)\n\n \n\n \n\n \n\n26"}